Armis Advisers’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$407K Buy
1,469
+320
+28% +$84.4K 0.03% 319
2026
Q2
$270K Sell
1,149
-21
-2% -$5.81K 0.02% 391
2026
Q1
$348K Sell
1,170
-74
-6% -$22K 0.03% 322
2025
Q4
$382K Buy
1,244
+348
+39% +$94.6K 0.04% 278
2025
Q3
$237K Buy
896
+28
+3% +$7.62K 0.02% 284
2025
Q2
$239K Buy
+868
New +$236K 0.02% 408

Other funds holding CME

Armis Advisers's CME Position: Q3 2026 in Review

Armis Advisers increased its CME Group (CME) stake by 28% in Q3 2026, buying an estimated $84.4K and bringing the position to 1,469 shares worth $407K. The position accounts for 0.03% of the portfolio, ranked #319.

Armis Advisers first reported a position in CME in Q2 2025 and has held it in 6 quarters since. 424 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Armis Advisers held 1,469 shares of CME Group worth $407K as of Q3 2026.
  • Armis Advisers bought 320 CME Group shares in Q3 2026, an estimated $84.4K.
  • CME Group made up 0.03% of Armis Advisers's portfolio in Q3 2026, its #319 holding.
  • Armis Advisers first reported a position in CME Group in Q2 2025 and has held it in 6 quarters since.
  • 424 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Armis Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.